News

What is new?

Read all news items about the AGE Reader, Diab-spot and DiagnOptics.

New key publication: large scale study in metabolic syndrome

Groningen, the Netherlands. June 13, 2017.

Recently a new scientific paper about the AGE Reader was published. It concerns an analysis of 78.671 non-diabetics subjects of the LifeLines study, a longitudinal cohort study with 167.000 participants. The aim of this study was to examine the association between the AGE Reader measurement and the presence of the metabolic syndrome as well as its individual components in a general population.

In this publication the authors conclude that the AGE Reader measurement was significantly associated with the presence of metabolic syndrome and some of its individual components. Please click here for the full-text version of this paper.

What is the added value of this validation paper for the AGE Reader? 

  • This study provides clinical validation in a very large study group of almost 80.000 subjects.
  • This study is performed in general population and not in a specific patient group.
  • This study provides new data for a broad application as a non-invasive screening tool to detect individuals at high risk for both cardiovascular disease and type 2 diabetes.

Share this link on:

Latest news items

  1. New key publication: large scale study in metabolic syndrome 2017
  2. Diagnoptics appoints DiosPharma as the new Korean distributor 2016
  3. Visit Diagnoptics at the EASD congress 2016 in Munich 2016
  4. Selista appointed as new Japanese distributor for the AGE Reader mu 2016
  5. Diagnoptics bei dem DDG Kongress in Berlin 2016
  6. Diagnoptics receives Chinese market approval for AGE Reader SU 2016
  7. New patent granted to Diagnoptics in Japan and EU. 2016
  8. Diagnoptics receives Japanese market approval for AGE Reader mu. 2015
  9. Diagnoptics nominated for Deloitte Technology Fast50 2015
  10. Scientific review emphasises need for AGE measurements and interventions 2015
More Information
Request information

Would you like to learn more about our products? Request any information you wish to receive here.

AGE Reader mu
Non-invasive cardiovascular risk assessment
Age Reader MU
The AGE Reader mu is the next generation AGE Reader that combines a high measurement quality standard with an innovative design, at a reduced pricelevel. The AGE Reader mu is a perfect tool for diabetologists and family doctors.

Read more »
Newsletter subscription

If you want to receive the newsletter with information about DiagnOptics' products, please send us your email address.

Downloads

Downloads about the AGE Reader and Diab-spot

About the company

Find information about Diagnoptics.

Information for patients

Find information about Diagnoptics' products and Advanced Glycation Endproducts.

Information for professionals

Find information about Advanced Glycation Endproducts, the AGE measurement and the clinical validation.